basic+care — Class II drug recall D-0332-2022
Terminated recall by Perrigo Company PLC, reported 2022-01-12, distributed nationwide. Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stabi
| Recall number | D-0332-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Perrigo Company PLC, Allegan, MI, United States |
| Recall initiated | 2021-07-27 |
| Classified | 2022-01-05 |
| Reported by FDA | 2022-01-12 |
| Terminated | 2022-11-08 |
| Distributed | Nationwide (US) |
| Quantity | 62,568 containers |
| Reason classes | specification failure |
| UPC / GTIN / UDI-DI | 00370030145362 |
| NDC | 00113-7425-78 |
| Lot numbers | 0CR0510, 0LR0361 |
| Expiration dates | 2021-09-30, 2022-04-30 |
Product
basic+care, allergy Fexofenadine Hydrochloride Tablets, 60 mg/Antihistamine, 12HR, 100 count bottle, Made in the Czech Republic, Distributed by: Perrigo Allergan, MI 49010, NDC 0113-7425-78 UPC 3 70030 14536 2
Reason for recall
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0332-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.